Sumitomo Mitsui Trust Group
VCYT icon

Sumitomo Mitsui Trust Group’s Veracyte VCYT Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34M Sell
1,055,656
-202,242
-16% -$7.49M 0.02% 543
2025
Q4 		$53M Sell
1,257,898
-224,185
-15% -$9.04M 0.03% 447
2025
Q3 		$50.9M Sell
1,482,083
-165,094
-10% -$4.74M 0.03% 470
2025
Q2 		$44.5M Sell
1,647,177
-616,762
-27% -$17.9M 0.03% 482
2025
Q1 		$67.1M Sell
2,263,939
-229,438
-9% -$8.75M 0.05% 365
2024
Q4 		$98.7M Sell
2,493,377
-259,006
-9% -$9.81M 0.07% 282
2024
Q3 		$93.7M Sell
2,752,383
-429,209
-13% -$12.1M 0.06% 297
2024
Q2 		$68.9M Sell
3,181,592
-165,844
-5% -$3.49M 0.05% 353
2024
Q1 		$74.2M Buy
3,347,436
+242,760
+8% +$5.92M 0.05% 381
2023
Q4 		$85.4M Sell
3,104,676
-68,900
-2% -$1.66M 0.06% 332
2023
Q3 		$70.9M Sell
3,173,576
-75,437
-2% -$1.94M 0.06% 358
2023
Q2 		$82.8M Sell
3,249,013
-46,103
-1% -$1.12M 0.06% 326
2023
Q1 		$73.5M Buy
3,295,116
+230,671
+8% +$5.58M 0.05% 379
2022
Q4 		$72.7M Buy
3,064,445
+60,527
+2% +$1.41M 0.06% 383
2022
Q3 		$49.9M Buy
3,003,918
+82,440
+3% +$1.86M 0.04% 484
2022
Q2 		$58.1M Sell
2,921,478
-93,563
-3% -$1.89M 0.04% 452
2022
Q1 		$83.1M Sell
3,015,041
-106,062
-3% -$3.03M 0.06% 377
2021
Q4 		$129M Buy
3,121,103
+164,724
+6% +$7.28M 0.08% 275
2021
Q3 		$137M Sell
2,956,379
-211,859
-7% -$9.24M 0.09% 257
2021
Q2 		$127M Sell
3,168,238
-91,284
-3% -$3.9M 0.07% 293
2021
Q1 		$175M Sell
3,259,522
-12,516
-0.4% -$721K 0.11% 206
2020
Q4 		$160M Buy
3,272,038
+288,583
+10% +$13.4M 0.1% 218
2020
Q3 		$96.9M Sell
2,983,455
-161,731
-5% -$5.14M 0.07% 315
2020
Q2 		$81.5M Sell
3,145,186
-142,281
-4% -$3.54M 0.06% 358
2020
Q1 		$79.9M Buy
3,287,467
+234,216
+8% +$5.9M 0.07% 315
2019
Q4 		$85.2M Buy
3,053,251
+289,015
+10% +$7.48M 0.07% 312
2019
Q3 		$66.3M Buy
2,764,236
+1,633,287
+144% +$43.4M 0.06% 356
2019
Q2 		$32.2M Buy
1,130,949
+534,049
+89% +$13.3M 0.03% 562
2019
Q1 		$14.9M Buy
+596,900
New +$11.4M 0.01% 670

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group's VCYT Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Veracyte (VCYT) stake by 16% in Q1 2026, selling an estimated $7.49M and leaving 1,055,656 shares worth $34M. The position accounts for 0.02% of the portfolio, ranked #543.

Sumitomo Mitsui Trust Group first reported a position in VCYT in Q1 2019 and has held it in 29 quarters since. The position peaked at $175M in Q1 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 1,055,656 shares of Veracyte worth $34M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 202,242 Veracyte shares in Q1 2026, an estimated $7.49M.
  • Veracyte made up 0.02% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #543 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Veracyte in Q1 2019 and has held it in 29 quarters since.
  • Sumitomo Mitsui Trust Group's Veracyte position peaked at $175M in Q1 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.